JAK1 and Tyk2 Activation by the Homologous Polycythemia Vera JAK2 V617F Mutation
Open Access
- 1 December 2005
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 280 (51) , 41893-41899
- https://doi.org/10.1074/jbc.c500358200
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Role of Tyrosine Kinases and Phosphatases in Polycythemia VeraSeminars in Hematology, 2005
- Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisPublished by Elsevier ,2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Mechanism of STAT3 Activation by Insulin-like Growth Factor I ReceptorJournal of Biological Chemistry, 2000
- Expression, Characterization, and Genomic Structure of Carp JAK1 Kinase GeneDNA and Cell Biology, 1996
- Interferon-α-dependent Activation of Tyk2 Requires Phosphorylation of Positive Regulatory Tyrosines by Another KinaseJournal of Biological Chemistry, 1996
- The membrane proximal region of the cytoplasmic domain of the growth hormone receptor is involved in the activation of Stat 3FEBS Letters, 1995
- Distinct Domains of the Protein Tyrosine Kinase tyk2 Required for Binding of Interferon-α/β and for Signal TransductionJournal of Biological Chemistry, 1995
- A protein tyrosine kinase in the interferon αβ signaling pathwayCell, 1992